The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Jemperli GlaxoSmithKline Australia Pty Ltd
Product name
Jemperli
Accepted date
Apr-2024
Active ingredients
dostarlimab
Proposed indication
For the treatment of endometrial cancer.
Application type
C (new indication)
Publication date
Apr-2024